Publications Agendas Board Actions Board Minutes Guidance Documents News Releases Newsletters Reports Subscribe to Updates Verify Messages Guidance Documents AUTOMATED PHARMACY SYSTEMSAutomated Pharmacy SystemsCompoundingFDA Letter - Retatrutide in Compounded Drug ProductsTerminal Distributor Requirements for Prescribers Engaged in Drug CompoundingOhio Licensed Outsourcing FacilitiesLicensure as an Outsourcing FacilityCompounding of GLP-1 Drug Products in OhioClarification on Allergen ExtractsPharmacy Compounding in OhioNon-Resident Pharmacy Compounding in OhioCompounding Product Quality Reporting FormConsult AgreementsPharmacist Consult Agreements with ProvidersControlled SubstancesReporting of MOUD to OARRS by Hospitals Under the EASY MAT ActFor Prescribers - New Limits on Prescription Opioids for Acute PainRequirements for Outpatient Opioid PrescriptionsStatement on the Descheduling of EpidiolexTemporary Removal of Dangerous Drugs from a Licensed Location by Dental AnesthesiologistsControlled Substance Inventory RequirementsPrescribing Opioids to MinorsFor Pharmacists - Limits on Prescription Opioids for Acute PainCRNA DEA Registration GuidanceCoronavirus (COVID-19) ResourcesAuthorization for Pharmacy Technician Trainees to Stock Automated Pharmacy Systems and Automated Drug Storage SystemsDelivery by Opioid Treatment ProgramsBoard of Pharmacy - COVID-19 Response EffortsDangerous DrugsTemporary Authorization to Move Dangerous Drugs in the Event of an EmergencyAddressing Shortages of Animal Euthanasia SolutionDelivery of Non-Self Injectable DrugsDispensing Multiple Simultaneous Refills of PrescriptionsDispensing Naltrexone without a PrescriptionDispensing Prescriptions by Prescribers Experiencing a Change of StatusExpedited Partner Therapy (EPT)Ohio Law on the Sale of Dextromethorphan ProductsS.C.U.B.A. Exemptions for Procurement of Medical OxygenUse of Contingency Stock License by Institutional FacilitiesDispensing Nicotine Replacement Therapy by PharmacistsPharmacist Nicotine Replacement Therapy Course and Screening Tool Approval RequestDispensing of an Emergency Refill of Medication Without a PrescriptionPersonally Furnishing Discharge Medications to Patients Leaving Correctional FacilitiesAdministration of Injections by PharmacistsCounterfeit Drugs Pocket CardDSCSA Dispenser GuideIssuing a Valid Prescription - What Every Prescriber Needs to KnowDrug Repository ProgramsDrug Repositories Operating in OhioOperating a Drug Repository ProgramDrug ShortagesDrug Shortage GuidanceResolutions to Address Shortages of IV and Peritoneal Dialysis SolutionsAlbuterol Shortage and Emergency Medical ServicesDrug Take BackDrug Disposal ResourcesDuty to Report and Continuous Quality ImprovementPharmacy Duty to ReportPharmacy Continuous Quality Improvement Programs for Dispensing ErrorsPharmacy Technician Duty to ReportPharmacy Intern Duty to ReportPharmacist Duty to ReportElectronic PrescribingApproved Third-Party IntermediariesMandatory Electronic Prescribing of Schedule II Controlled SubstancesEmergency Medical ServicesDEA Regulations for Emergency Medical ServicesEmergency Medical Services - Inspection Guide and FAQFaith-Based Volunteer Ambulance ServicesEpinephrinePharmacy Laws on Epinephrine AutoinjectorsProcurement of Epinephrine Autoinjectors by Schools, Camps and Qualified EntitiesSample Pharmacy Dispensing for Epinephrine AutoinjectorsU.S. Food and Drug AdministrationU.S. Food and Drug Administration Guidance Document Applicability in OhioImmunizationsImmunizations by Pharmacists and Pharmacy InternsImmunizations by Pharmacy TechniciansPharmacist Use of the Ohio Impact Statewide Immunization Information SystemApproved Immunization CoursesIV Therapy & Medical SpasMed Spas and IV Hydration Clinics - Tips for PatientsTen Common Prescriber Clinic and Medical Spa ViolationsJoint Regulatory Statement on the Operation of Retail IV Therapy Clinics in OhioKey BoxesUse of Key Boxes by First Responders to Obtain Access to a PharmacyKratom and Kratom-Related ProductsMitragynine-Related Compounds - CSI CommentsClassification of Mitragynine-Related Compounds as Schedule I Controlled SubstancesConsumer and Retailer Notice - Kratom-Related Products Now Illegal in OhioClassification of Mitragynine-Related Compounds as Schedule I Controlled Substances - Emergency RuleClassification of Mitragynine Compounds as Schedule I Controlled SubstancesConsumer and Retailer Notice - SpanishConsumer and Retailer Notice - SomaliConsumer and Retailer Notice - NepaliConsumer and Retailer Notice - Simplified ChineseConsumer and Retailer Notice - ArabicMedical Marijuana Control ProgramParticipation in the Ohio Medical Marijuana Control ProgramAdvanced Pharmacy Practice Experience (APPE) for Pharmacy Students at DispensariesOutpatient Pharmacy Minimum StandardsOutpatient Pharmacy Minimum StandardsOhio Automated Rx Reporting SystemNew OARRS Rules - Effective 7.1.2026OARRS Fact Sheet for PharmacistsReporting Drug Enforcement Administration Registration Number Suffixes by HospitalsOARRS Access by Fatality Review CommitteesReporting Naltrexone Products to OARRS - Effective 3.19.2019Mandatory OARRS Registration and RequestsWhen to Check OARRS - Pocket Card - Prescribers and PharmacistsWhen to Check OARRS - One Pager - PharmacistsSometimes We Just Have to Say No - FlierOARRS Rules & Corresponding ResponsibilityOverdose Prevention ResourcesApproval of Instruments to Reduce Drug Poisoning Guidance DocumentInstruments to Reduce Drug PoisoningOverdose Prevention ResourcesSuspension/ProbationTolling Violation List Suspension-ProbationProtocolsUse of Protocols for Administration of Contrast and RadiopharmaceuticalsUse of Protocols to Initiate or Adjust MedicationsRemote Pharmacy ServicesRemote Order and Prescription Entry by Pharmacy Technicians and Pharmacy InternsRemote Medication Order and Prescription Processing by PharmacistsSuspicious Order MonitoringSuspicious Order Monitoring and Due DiligenceTheft or Loss ReportingReporting Theft or Loss of Dangerous Drugs and Drug DocumentsSubmitting Theft or Loss ReportsBest Practices to Prevent Drug Diversion